Answers are grounded in this paper and cite their sources.
Heart failure (HF) remission involves the normalization of cardiac function but is accompanied by a risk of relapse. The key to achieving (complete) recovery may lie in identifying genes that remain persistently dysregulated despite phenotypic normalization. We used a mouse model of non-ischemic HF recovery to identify persistently dysregulated genes in phenotypically recovered myocardium compared to HF. RNA-seq data from male C57BL/6 mice that underwent HF induction followed by phenotypic recovery were analyzed. Differential expression analyses identified 18 persistently altered genes: 17 were upregulated, and 1 was downregulated. Notably, the only downregulated gene was the transferrin receptor gene (Tfrc), whereas transferrin (Trf) was upregulated, suggesting a role of ferroptosis pathways. Persistently dysregulated genes, especially those related to iron metabolism and ferroptosis, are potential therapeutic targets to sustain cardiac recovery from HF.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: